Oncopeptides AB
STO:ONCO

Watchlist Manager
Oncopeptides AB Logo
Oncopeptides AB
STO:ONCO
Watchlist
Price: 1.524 SEK 0.26% Market Closed
Market Cap: 322m SEK

Wall Street
Price Targets

ONCO Price Targets Summary
Oncopeptides AB

Wall Street analysts forecast ONCO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ONCO is 5.789 SEK with a low forecast of 1.717 SEK and a high forecast of 14.7 SEK.

Lowest
Price Target
1.717 SEK
13% Upside
Average
Price Target
5.789 SEK
280% Upside
Highest
Price Target
14.7 SEK
865% Upside
Oncopeptides AB Competitors:
Price Targets
688192
Dizal Jiangsu Pharmaceutical Co Ltd
15% Upside
301080
Acrobiosystems Co Ltd
7% Upside
RCKT
Rocket Pharmaceuticals Inc
409% Upside
TGTX
TG Therapeutics Inc
8% Upside
BPMC
Blueprint Medicines Corp
0% Downside
MAB
Mabion SA
2% Downside
TECX
AVROBIO Inc
266% Upside

Revenue
Forecast

Revenue Estimate
Oncopeptides AB

The compound annual growth rate of Oncopeptides AB's revenue for the next 2 years is 158%.

N/A
Past Growth
158%
Estimated Growth
Estimates Accuracy
-23%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Oncopeptides AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

Net Income Estimate
Oncopeptides AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-50%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ONCO's stock price target?
Price Target
5.789 SEK

According to Wall Street analysts, the average 1-year price target for ONCO is 5.789 SEK with a low forecast of 1.717 SEK and a high forecast of 14.7 SEK.

What is Oncopeptides AB's Revenue forecast?
Projected CAGR
158%

The compound annual growth rate of Oncopeptides AB's revenue for the next 2 years is 158%.

Back to Top